Intervest β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
Genkore develops ultra-compact gene-editing technology to create therapeutic treatments for neurodegenerative diseases such as Huntington's and ALS.
BiotechDeep TechMedical DevicesSeoul, KR
Kim Yong-sam
Co-investorsAju IB Invesment CorporationKiwoom Investment
Aerodyne is a drone technology and data analytics provider that offers Drone-as-a-Service and an AI-powered, cloud-based asset management platform (vertikaliti) for inspecting industrial assets such as powerlines, wind turbines, and solar installations.
AI & Machine LearningMobility & TransportationRoboticsSaaS
Co-investors500 GlobalDRONE FUNDUntroD CapitalGobi PartnersKWAPPETRONAS Ventures+1 more
Aniai develops an automated grill system designed for commercial kitchens to improve consistency and reduce labor dependency at the busiest station.
FoodTechHardwareRoboticsNew York City, US
minsu ji λ(Founder)in
Co-investorsLotte VenturesKorea Development Bank
Banksalad is a financial comparison platform that matches consumers with personalized banking products and services based on their financial profiles.
B2B MarketplacesFintechMarketplacesSeoul, KR
Co-investorsAtinum Investment Co. Ltd.Dunamu & PartnersKiwoom InvestmentWe VenturesCompany K PartnersIMM Investment+2 more
Dalpha builds AI technology, including a system it calls the Cobra World Model, focused on predicting human behavior to generate insights.
AI & Machine LearningEnterprise Software
Yoo Seon-bin(Co-Founder)Kim Do-gyun(CEO)
Co-investorsDunamu & PartnersSazzeDSC InvestmentIMM InvestmentMirae Asset Venture InvestmentPrimer Sazze Partners
Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab.
AI & Machine LearningBiotechDigital HealthHealthtech
YoungSeok Ju(Founder)in
Co-investorsDunamu & PartnersSchmidtDSC InvestmentIMM Investment
Liner is an AI research agent and search engine that provides source-cited answers, aiming to minimize hallucinations.
AI & Machine LearningEdTechFuture of WorkSaaS
Brian(Chanmin) Woo(Founder)in
Co-investorsAtinum Investment Co. Ltd.KB SecuritiesKorea Development BankLB InvestmentSTIC Ventures
Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.
BiotechHouston, US
Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)
BoardSteven Gillis(Director)in
Co-investors3B Future Health FundCanaan PartnersGreatPoint VenturesRiverVest Venture PartnersARCH Venture PartnersBering Capital+3 more
SparkPlus provides flexible and serviced office spaces for companies, including fully-equipped offices for teams of 50 or fewer, dedicated desks, and lounge areas, along with space operation, maintenance, and asset management services.
Future of WorkPropTech
Co-investorsAju IB Invesment CorporationWe VenturesSTIC Ventures
Upstage builds advanced language models and document processing engines that help organizations improve workflow efficiency and process automation for the future of work.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaSSeoul, KR
Sung Kim(Founder)inHwalsuk Lee(Founder)inLucy Park(Founder)in
Co-investorsCompany K PartnersPrimer Sazze PartnersSK NetworksPremier PartnersSazzeTBT+7 more
Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.
HealthtechMedical DevicesRoboticsNetherlands, NL
Toon Overbeeke(Co-founder & CEO)inBrian Joseph(Co-founder)in
Co-investorsNYBC VenturesSonder CapitalInvest-NL
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.